1. Home
  2. CLDI vs HTCR Comparison

CLDI vs HTCR Comparison

Compare CLDI & HTCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Calidi Biotherapeutics Inc.

CLDI

Calidi Biotherapeutics Inc.

HOLD

Current Price

$0.22

Market Cap

5.6M

Sector

Health Care

ML Signal

HOLD

Logo Heartcore Enterprises Inc.

HTCR

Heartcore Enterprises Inc.

HOLD

Current Price

$3.52

Market Cap

6.5M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLDI
HTCR
Founded
2014
2009
Country
United States
Japan
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
5.6M
6.5M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
CLDI
HTCR
Price
$0.22
$3.52
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
3.7M
62.9K
Earning Date
05-14-2026
05-14-2026
Dividend Yield
N/A
87.84%
EPS Growth
N/A
414.29
EPS
N/A
0.22
Revenue
N/A
$30,407,229.00
Revenue This Year
N/A
$123.26
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$14.18
Revenue Growth
N/A
39.19
52 Week Low
$0.19
$0.15
52 Week High
$7.32
$3.97

Technical Indicators

Market Signals
Indicator
CLDI
HTCR
Relative Strength Index (RSI) 33.40 67.14
Support Level $0.21 $0.30
Resistance Level $0.30 $3.97
Average True Range (ATR) 0.03 0.33
MACD 0.01 -0.10
Stochastic Oscillator 26.25 86.51

Price Performance

Historical Comparison
CLDI
HTCR

About CLDI Calidi Biotherapeutics Inc.

Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.

About HTCR Heartcore Enterprises Inc.

HeartCore Enterprises Inc is a software development company. The company provides software through two business units. The first business unit includes a customer experience management business. The customer experience management platform includes marketing, sales, service, and content management systems, as well as other tools and integrations that enable companies to attract and engage customers throughout the customer experience. It also provides education, services and support to help customers be successful with the CXM Platform. The second business unit, DX division, is a digital transformation business that provides customers with robotics process automation, process mining, and task mining to accelerate the digital transformation of enterprises.

Share on Social Networks: